And although it’s rare, if you have severe axSpA, the bones in your spine can eventually fuse. This causes a permanent loss of motion and increases your risk of fractures. “The fused spine can ...

Clues that you have a frontal sinus infection include: Fever and/or chills Nasal discharge that is thick, colored, and profuse Pain that is worse when you bend over Loss of smell and taste (in some ...

We will see a lot of cold air in place over the next several days. This cold air will meet up with a frontal system that will move through our area on our Tuesday evening and into our Wednesday ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...

Fetal MRI can be useful for analysis of the fetal spine if there is a suggestion of severe scoliosis and there is concern for diastematomyelia or vertebral malformations. Three-dimensional ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York City ...

therefore, in this respect, to differ more from the nose-case of the ape, than it does owing to any great development of the nasal bones.

(Nasdaq: TLSA) ("Tiziana” or the "Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...

Shares of Tiziana Life Sciences rose after the company said it received positive results from its nasal anti-CD3 monoclonal antibody in traumatic spinal cord injury. The stock was up 5.3% to 84 ...

In these studies, the preclinical model was subjected to a spinal cord injury and then was treated with nasal anti-CD3, resulting in notable advancements in motor functions. Furthermore ...

(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...

Introduction: The Consortium for Spinal Cord Medicine's inaugural Clinical Practice Guideline for Bone Health and Osteoporosis Management for Individuals with Spinal Cord Injury or Disease (CSCM-CPG) ...